DTPPJJHEFXQELB-PXIJXODZSA-N
C24H20F10N6O4 — CID 155252688
Data last refreshed: (MolForge compound catalog, from PubChem)
About DTPPJJHEFXQELB-PXIJXODZSA-N
DTPPJJHEFXQELB-PXIJXODZSA-N (PubChem CID 155252688) has the molecular formula C24H20F10N6O4 and a molecular weight of 646.44 g/mol. Its IUPAC name is 5-[4-amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-N-[(3R,4S)-4-fluoro-1-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl]pyrrolidin-3-yl]-2-(2,2,2-trifluoroethoxy)benzamide.
Molecular Properties
| Compound Name | DTPPJJHEFXQELB-PXIJXODZSA-N |
|---|---|
| PubChem CID | 155252688 |
| Molecular Formula | C24H20F10N6O4 |
| Molecular Weight | 646.44 g/mol |
| Exact Mass | 646.14 |
| IUPAC Name | 5-[4-amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-N-[(3R,4S)-4-fluoro-1-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoyl]pyrrolidin-3-yl]-2-(2,2,2-trifluoroethoxy)benzamide |
| SMILES | C[C@@](O)(C(=O)N1C[C@H](F)[C@H](NC(=O)c2cc(-c3cc(C(F)(F)F)c4c(N)ncnn34)ccc2OCC(F)(F)F)C1)C(F)(F)F |
| InChI | InChI=1S/C24H20F10N6O4/c1-21(43,24(32,33)34)20(42)39-6-13(25)14(7-39)38-19(41)11-4-10(2-3-16(11)44-8-22(26,27)28)15-5-12(23(29,30)31)17-18(35)36-9-37-40(15)17/h2-5,9,13-14,43H,6-8H2,1H3,(H,38,41)(H2,35,36,37)/t13-,14+,21+/m0/s1 |
| InChIKey | DTPPJJHEFXQELB-PXIJXODZSA-N |
| XLogP | 3.53 |
| TPSA | 135.08 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 646.44 |
| LogP ≤ 5 | 3.53 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155252688 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.